MediPharm Labs, Canopy Growth, and OrganiGram get some love from three of our contributors who cover the marijuana space.
News & Analysis: Constellation Brands
Pure-play pot stock or its big partner? Here's which stock looks more attractive over the long run.
One Wall Street firm significantly reduced its price target for Canopy Growth.
What you need to know before making your first consumer staples investment.
Why was Canopy Growth CEO Bruce Linton removed by Constellation Brands?
Investors cheered the beer titan's Q1 results.
Linton's fate was sealed after Canopy released its full-year operating results.
Only around 1 in 4 marijuana stocks ended the second quarter higher.
They may not be producers and growers per se, but these associated pot stocks pass along the green in their own way.
Here's what the big alcoholic beverage maker likes -- and doesn't like -- about its Canadian cannabis partner.